212 related articles for article (PubMed ID: 36331203)
1. The profile of patients with haemophilia managed at a haemophilia treatment centre in Pretoria, Gauteng.
Mafisa L; Dlova AN; Moodley V
S Afr Fam Pract (2004); 2022 Oct; 64(1):e1-e7. PubMed ID: 36331203
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of treatment and outcome for patients with haemophilia A and haemophilia B on extended half-life (EHL) factor products: A 12-month data analysis.
George C; Parikh S; Carter T; Mccosker J; Carlino S; Tran H
Haemophilia; 2023 Sep; 29(5):1283-1290. PubMed ID: 37565529
[TBL] [Abstract][Full Text] [Related]
3. Outcome measures in haemophilia: a systematic review.
Boehlen F; Graf L; Berntorp E
Eur J Haematol Suppl; 2014 Aug; 76():2-15. PubMed ID: 24957102
[TBL] [Abstract][Full Text] [Related]
4. Cancer detection and management in patients with haemophilia: a retrospective European multicentre study.
Biron-Andreani C; de Moerloose P; D'oiron R; Chambost H; Schved JF; Hermans C
Haemophilia; 2014 Jan; 20(1):78-82. PubMed ID: 23919383
[TBL] [Abstract][Full Text] [Related]
5. Clinical management of older persons with haemophilia.
Hermans C; de Moerloose P; Dolan G
Crit Rev Oncol Hematol; 2014 Feb; 89(2):197-206. PubMed ID: 23953685
[TBL] [Abstract][Full Text] [Related]
6. Haemophilia B: Where are we now and what does the future hold?
Dolan G; Benson G; Duffy A; Hermans C; Jiménez-Yuste V; Lambert T; Ljung R; Morfini M; Zupančić Šalek S
Blood Rev; 2018 Jan; 32(1):52-60. PubMed ID: 28826659
[TBL] [Abstract][Full Text] [Related]
7. Severe and moderate haemophilia A and B in US females.
Di Michele DM; Gibb C; Lefkowitz JM; Ni Q; Gerber LM; Ganguly A
Haemophilia; 2014 Mar; 20(2):e136-43. PubMed ID: 24533955
[TBL] [Abstract][Full Text] [Related]
8. Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics.
Forsyth AL; Gregory M; Nugent D; Garrido C; Pilgaard T; Cooper DL; Iorio A
Haemophilia; 2014 Jan; 20(1):44-51. PubMed ID: 23902228
[TBL] [Abstract][Full Text] [Related]
9. Haemophilia joint health score (HJHS) usage, patterns and outcome data in patients with haemophilia A and haemophilia B in Australia: A descriptive study using the Australian Bleeding Disorders Registry (ABDR).
George C; Parikh S; Carter T; Morris A; Cramey C; Mcelroy K; Tran H
Haemophilia; 2023 Jul; 29(4):1135-1141. PubMed ID: 37335559
[TBL] [Abstract][Full Text] [Related]
10. Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach.
Alito A; Bellone F; Portaro S; Leonardi G; Cannavò V; Coppini F; Leonetti D; Catalano A; Squadrito G; Fenga D
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298347
[TBL] [Abstract][Full Text] [Related]
11. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
[TBL] [Abstract][Full Text] [Related]
12. Preventing bleeds by treatment: new era for haemophilia changing the paradigm.
Marijke van den Berg H
Haemophilia; 2016 Jul; 22 Suppl 5():9-13. PubMed ID: 27405669
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment for coronary heart disease in patients with haemophilia: a single centre study in the United States.
Sait AS; Kuo A; Bettencourt R; Bergstrom J; Allison M; von Drygalski A
Haemophilia; 2014 Nov; 20(6):763-70. PubMed ID: 24893625
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors.
Ter-Zakarian A; Barnes RFW; Kruse-Jarres R; Quon DV; Jackson S; Sun HL; von Drygalski A
Haemophilia; 2022 Nov; 28(6):977-985. PubMed ID: 35768896
[TBL] [Abstract][Full Text] [Related]
15. Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population.
Nugent D; Kalnins W; Querol F; Gregory M; Pilgaard T; Cooper DL; Iorio A
Haemophilia; 2015 Jan; 21(1):e26-38. PubMed ID: 25377442
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).
Sharathkumar AA; Soucie JM; Trawinski B; Greist A; Shapiro AD
Haemophilia; 2011 Jul; 17(4):597-604. PubMed ID: 21323799
[TBL] [Abstract][Full Text] [Related]
17. A new measure to assess pain in people with haemophilia: The Multidimensional Haemophilia Pain Questionnaire (MHPQ).
Paredes AC; Costa P; Almeida A; Pinto PR
PLoS One; 2018; 13(11):e0207939. PubMed ID: 30485381
[TBL] [Abstract][Full Text] [Related]
18. [Prophylaxis in patients with haemophilia complicated by inhibitors].
Paweł Ł
Pol Merkur Lekarski; 2011 Mar; 30(177):211-4. PubMed ID: 21545000
[TBL] [Abstract][Full Text] [Related]
19. Physiotherapy outcome measures of haemophilia acute bleed episodes: What matters to patients?
Bradshaw E; McClellan C; Whybrow P; Cramp F
Haemophilia; 2019 Nov; 25(6):1066-1072. PubMed ID: 31522466
[TBL] [Abstract][Full Text] [Related]
20. Haemophilia in Côte d'Ivoire (the Ivory Coast) in 2017: Extensive data collection as part of the World Federation of Hemophilia's twinning programme.
Lambert C; Meité N; Sanogo I; Lobet S; Adjambri E; Eeckhoudt S; Hermans C
Haemophilia; 2019 Mar; 25(2):236-243. PubMed ID: 30748057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
